arrow
Y

Yirui Zhai

cancer hospital
H指数:17
被引数:926

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal dynamics and recovery of lymphocytes in patients with breast cancer receiving radiotherapy without chemotherapy after breast-conserving surgery: A second analysis of a phase III randomized trial of HYPOfractionation in BREAST radiotherapy for Chinese women (CHN HYPOBREAST)

乳腺癌保乳术后接受单纯放疗(无化疗)的患者外周血淋巴细胞纵向动力学及恢复情况:中国女性乳腺癌放疗低分割照射III期随机试验(CHN HYPOBREAST)的二次分析

2026-09-290
PRE
Simultaneous integrated boost versus sequential boost for postoperative intensity-modulated radiotherapy of extremity and trunk soft tissue sarcomas: a propensity score matching-based large-scale retrospective analysis

肢体和躯干软组织肉瘤术后调强放疗中同时整合加量与序贯加量的比较:一项基于倾向性评分匹配的大规模回顾性分析

2026-09-240
OAAI
Prognostic and Treatment Values of Baseline Metabolic Tumor Volume in Early-stage Extranodal NK/T-cell Lymphoma in the Modern Treatment Era

基线代谢肿瘤体积在当代治疗时代早期结外NK/T细胞淋巴瘤中的预后和治疗价值

2026-07-290
PRE
Can ADC changes help mRECIST or LI-RADS treatment response algorithm better diagnose pathological response of HCC after preoperative radiotherapy? Secondary analysis of a prospective phase 2 trial

ADC值的变化能否帮助mRECIST或LI-RADS治疗反应算法更准确地诊断术前放疗后HCC的病理反应?——前瞻性二期试验的二次分析

2025-10-160
OA
Simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal squamous cell carcinoma: A multicenter, open-label, randomized, phase III clinical trial

同步整合推量调强放射治疗联合或不联合同期化疗在食管鳞状细胞癌患者中的应用:一项多中心、开放标签、随机、III期临床试验

2025-10-150
PRE
Simultaneous Integrated Dose Reduction Radiotherapy Versus Conventional Fractionated Radiotherapy With Chemotherapy for Limited-Stage Small-Cell Lung Cancer in the Modern Treatment Era: a Phase III, Randomized Clinical Trial (SDR-RT trial)

同步整合剂量降低放射疗法与常规分割放射疗法联合化疗治疗现代治疗时代局限期小细胞肺癌的随机III期临床试验(SDR-RT试验)

2025-10-140
PRE
Methodological and Reporting Rigor in Non-Inferiority and Equivalence Trials for Multimodality Cancer Treatment: Lessons from Breast Cancer Radiotherapy

多模式癌症治疗方法中非劣效性和等效性试验的方法学与报告严谨性:来自乳腺癌放疗的启示

2025-10-100
OAAI
Dosimetric and clinical predictors for radiation esophagitis in patients with breast cancer undergoing conventional fractionated regional nodal irradiation: A prospective study

乳腺癌患者接受常规分割区域性淋巴结放疗后发生放射性食管炎的剂量学及临床预测因素:一项前瞻性研究

2025-09-180
PRE
Prospective cohort study to validate esophageal dose constraints and predictive models for esophagitis in patients with breast cancer undergoing hypofractionated regional nodal radiotherapy

前瞻性队列研究,旨在验证接受局部区域淋巴结低分割放射治疗的乳腺癌患者中,食管炎的剂量限制和预测模型。

2025-09-060
PRE
Combined radiation and immune checkpoint inhibitor therapy for metastatic or recurrent hepatocellular carcinoma: a real-world study of 108 patients

联合放疗和免疫检查点抑制剂治疗转移性或复发性肝细胞癌:一项108例患者的真实世界研究

2025-08-040
OA
Low-dose moderate hypofractionated radiotherapy for indolent non-Hodgkin lymphoma: a multicentre, single-arm, phase 2 trial

低剂量中等分次放射疗法治疗惰性非霍奇金淋巴瘤:一项多中心、单臂、II期试验

2025-05-020
PRE
An upfront patient selection strategy based on personalized data-driven computed tomography generation for deep inspiration breath-hold in breast radiotherapy

一种基于个性化数据驱动的深吸气屏气乳腺癌放疗中计算机断层扫描生成的患者早期筛选策略

2025-05-010
PRE
Phase II study with sorafenib plus radiotherapy for advanced HCC with portal and/or hepatic vein tumor thrombosis

II期研究:sorafenib联合放射治疗用于伴有门静脉和/或肝静脉肿瘤血栓的晚期HCC

2025-03-010
OAAI
Impact of locoregional recurrence versus distant metastasis on overall survival in patients with Non-Small cell lung cancer after Surgery: A secondary analysis of PORT-C RCT

手术后的非小细胞肺癌患者中,局部区域复发与远处转移对总生存期的影响:PORT-C随机对照试验的二次分析

2025-01-010
PRE
Chinese Expert Consensus on the Combination of Targeted Therapy and Immunotherapy with Locoregional Therapy for Intermediate/Advanced Hepatocellular Carcinoma

中晚期肝癌靶向治疗联合局部治疗中国专家共识

2024-10-210
OAAI
Dosimetric benefit and clinical feasibility of deep inspiration breath-hold and volumetric modulated arc therapy-based postmastectomy radiotherapy for left-sided breast cancer

基于深吸气屏气和容积调强弧治疗的左侧乳腺癌术后放疗的剂量学效益和临床可行性

2024-10-201
OAAI
Association of overall survival benefit of radiotherapy with progression-free survival after chemotherapy for diffuse large B-cell lymphoma: A systematic review and meta-analysis
2024-09-010
OAAI